Juan Carlos Gomez-Esteban, MD, PhD, is the director of the Neurodegenerative Disease Group at Biocruces Health Research Institute (Baracaldo, Spain); full-time lecturer in the Department of Neurosciences of the University of the Basque Country (UPV/EHU); and consultant in the Movement Disorders and Autonomic Disorders Unit at University Hospital of Cruces (UHC). He majored in medicine at the UPV/EHU, specialized in neurology at UHC and received his PhD in neuroscience from UPV/EHU in 2008, after which he performed a postdoctoral training in the Autonomic Center of New York University.

His research interests include the autonomic nervous system, movement disorders, and Parkinson's disease's pathophysiology and genetics. Dr. Gomez-Esteban co-directs the group of Movement Disorders and Autonomic Disorders Unit at UHC, which pioneered the identification of the E46K mutation of the alpha-synuclein gene in 2004. His group is highly focused on phenotypic characterization of genetic variants of Lewy body diseases.